Turn Therapeutics' eczema drug shows rapid response in mid-stage data

Bradley Burnam, Turn Therapeutics CEO June 1, 2026 08:51 AM EDT R&D Turn Ther­a­peu­tic­s' eczema drug shows rapid re­sponse in mid-stage da­ta Ayisha Sharma News Reporter Cal­i­for­nia biotech Turn Ther­a­peu­tics shared Phase 2 da­ta for its top­i­cal atopic der­mati­tis treat­ment that show pa­tients ex­pe­ri­enced symp­tom im­prove­ment faster than usu­al. In an … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER